PAX-5 (BSAP) Antibody, anti-human/mouse, PE-Vio® 770, REAfinity™ 130-100-634 from Miltenyi Biotec | Biocompare.com

Be the first to write a review!

Citations:

Supplier Page from
Miltenyi Biotec for
PAX-5 (BSAP) Antibody, anti-human/mouse, PE-Vio® 770, REAfinity™

Miltenyi Biotec's PAX-5 (BSAP) Antibody, anti-human/mouse, PE-Vio® 770, REAfinity™ is a Human monoclonal antibody. The PAX-5 (BSAP) Antibody, anti-human/mouse, PE-Vio® 770, REAfinity™ was generated using PAX5 as the antigen. It reacts with Human, and Mouse. This antibody has been shown to work in applications such as: Flow Cytometry.

Product Specs
ItemPAX-5 (BSAP) Antibody, anti-human/mouse, PE-Vio® 770, REAfinity™
CompanyMiltenyi Biotec
Price Pricing Info Supplier Page View Company Product Page
Catalog Number130-100-634
Quantity30 tests in 300 µL
ApplicationsIntracellular flow cytometry
Conjugate/TagPE-Vio 770
FormatReagents are supplied in buffer containing stabilizer and 0.05% sodium azide
Reactivityhuman, mouse
TargetPAX-5 (BSAP)
IsotypeIgG1
CloneREA140
Hosthuman cell line
Antibody TypePrimary antibodies, Recombinant antibodies
Clonalitymonoclonal
Regulatory StatusFor research use only
Concentration1:11
ModificationsRecombinantly engineered
Research AreaFor research use only
NCBI Full Gene Namepaired box 5
NCBI Gene AliasesPax-5, Pax, BSAP, EBB-1, KLP, ALL3

Add to Compare List

Miltenyi Biotec

Local Office

Miltenyi Biotec

Miltenyi Biotec Inc.

2303 Lindbergh Street

Auburn, CA 95602

United States

Phone: Phone: +1 530 888 8871
Toll Free: 800 FOR MACS
Fax: +1 530 888 8925

Email: macs@miltenyibiotec.com

Company Profile

Website: www.miltenyibiotec.com

International Office

Miltenyi Biotec

Miltenyi Biotec B.V. & Co. KG

Friedrich-Ebert-Straße 68

51429 Bergisch Gladbach

Germany

Phone: +49 2204 8306-0
Fax: +49 2204 8306-235

Email: macs@miltenyibiotec.de

Company Profile

Website: www.miltenyibiotec.com

(1) Histone acetyltransferase p300 acetylates Pax5 and strongly enhances Pax5-mediated transcriptional activityThe Journal of biological chemistryApril 22, 2011He T, Hong SY, Huang L, Xue W, Yu Z, Kwon H, Kirk M, Ding SJ, Su K, Zhang Z.

(2) Identification of Pax5 target genes in early B cell differentiationJournal of immunology (Baltimore, Md. : 1950)February 1, 2008Pridans C, Holmes ML, Polli M, Wettenhall JM, Dakic A, Corcoran LM, Smyth GK, Nutt SL.

(3) PAX5/TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cellsCancer researchJanuary 1, 2008Fazio G, Palmi C, Rolink A, Biondi A, Cazzaniga G.

Be the First to Write a Review!